Danielle Brill Analyst Performance

Danielle Brill is a stock analyst at Raymond James Financial, covering 21 publicly traded companies across a range of sectors. Over the past year, Danielle Brill has issued 10 stock ratings, including buy and hold recommendations. While full access to Danielle Brill's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Danielle Brill's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

38 Last 8 Years

Buy Recommendations

94.74% 36 Buy Ratings

Companies Covered

21 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	94.7%	36 ratings
Hold	5.3%	2 ratings
Sell	0.0%	0 ratings

Out of 38 total stock ratings issued by Danielle Brill at Raymond James Financial, the majority (94.7%) have been Buy recommendations, followed by 5.3% Hold.

Best & Worst Calls

• Best Call

  0000.0%

  MNTA

  Sep 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  XLRN

  Jul 2020

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	95.2% of companies on NASDAQ	20 companies
NYSE	4.8% of companies on NYSE	1 company

Danielle Brill, an analyst at Raymond James Financial, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 20 companies	95.2%
	Finance 1 company	4.8%

Danielle Brill of Raymond James Financial specializes in stock coverage within the Medical sector, with additional focus on Finance companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 11 companies	52.4%
PHARMACEUTICAL PREPARATIONS 4 companies	19.0%
MED - DRUGS 2 companies	9.5%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 2 companies	9.5%
MED - GENERIC DRG 1 company	4.8%
REAL ESTATE INVESTMENT TRUSTS 1 company	4.8%

Danielle Brill's Ratings History at Raymond James Financial

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
VRTX Vertex Pharmaceuticals	9/2/2025	Initiated Coverage	$401.00		Market Perform	$0.00 00.00% ROI
HRMY Harmony Biosciences	7/21/2025	Initiated Coverage	$35.20	$48.00	Buy	$0.00 00.00% ROI
PVLA Palvella Therapeutics	7/21/2025	Initiated Coverage	$29.51	$56.00	Buy	$0.00 00.00% ROI
TECX Tectonic Therapeutic	7/21/2025	Initiated Coverage	$21.91	$64.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	7/21/2025	Initiated Coverage	$132.02	$163.00	Buy	$0.00 00.00% ROI
BBIO BridgeBio Pharma	7/21/2025	Initiated Coverage	$46.51	$66.00	Buy	$0.00 00.00% ROI
CNTA Centessa Pharmaceuticals	7/21/2025	Initiated Coverage	$15.69	$30.00	Buy	$0.00 00.00% ROI
JCAP Jernigan Capital	7/21/2025	Initiated Coverage	$16.70	$24.00	Buy	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	7/21/2025	Initiated Coverage	$320.53	$385.00	Buy	$0.00 00.00% ROI
IRON Disc Medicine	7/21/2025	Initiated Coverage	$57.77	$86.00	Buy	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.